The Efficacy of Drugs for the Treatment of LUTS/BPH, A Study in 6 European Countries
- 1 January 2007
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 51 (1) , 207-216
- https://doi.org/10.1016/j.eururo.2006.06.012
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic HyperplasiaEuropean Urology, 2004
- Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients—PERMAL Study Subset AnalysisEuropean Urology, 2004
- Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasiaExpert Opinion on Pharmacotherapy, 2004
- Optimising the Medical Management of Benign Prostatic HyperplasiaEuropean Urology, 2004
- A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaProstate Cancer and Prostatic Diseases, 2003
- Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: A short‐term open, randomized multicenter studyInternational Journal of Urology, 2000
- Clinical Pharmacology of α1-Adrenoceptor AntagonistsEuropean Urology, 1999
- Clinical comparison of selective and non‐selective &agr;1A‐adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing dosesBritish Journal of Urology, 1997
- Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia)British Journal of Urology, 1997
- ??1-Blockers vs 5??-Reductase Inhibitors in Benign Prostatic HyperplasiaDrugs & Aging, 1995